Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2019/0119399 CHIMERIC ANTIGEN RECEPTORS
Provided herein are therapeutic polypeptides, e.g., chimeric antigen receptors, able to direct an immune cell, e.g., a T lymphocyte to a target antigen, and...
2019/0119398 ANTI-SURVIVIN ANTIBODIES FOR CANCER THERAPY
Provided are survivin specific antibodies, nucleic acids encoding the antibodies and methods for treating tumors comprising survivin-expressing cells by...
2019/0119397 PLECTIN-1 BINDING ANTIBODIES AND USES THEREOF
Aspects of the disclosure provide compositions and methods for treating cancer characterized by surface expression of plectin-1. In some embodiments, the...
2019/0119396 Anti-SIRP-Alpha Antibodies and Related Methods
Anti-SIRP.alpha. antibodies, including multi-specific anti-SIRP.alpha. antibodies, are provided, as are related compositions and methods. The antibodies of the...
2019/0119395 COMBINATION THERAPY USING AN ANTI-FUCOSYL-GM1 ANTIBODY AND AN ANTI-CD137 ANTIBODY
This disclosure provides combination therapy for treating a subject, such as a subject afflicted with a lung cancer, comprising administering to the subject an...
2019/0119394 COMPOSITIONS AND METHODS FOR TREATING PANCREATITIS AND PAIN WITH DEATH RECEPTOR AGONISTS
Death receptor 5 (DR5) agonist compositions and methods for treating pancreatitis have been developed. The compositions include Tumor Necrosis Factor-related...
2019/0119393 PROLONGED INHIBITION OF INTERLEUKIN-6 MEDIATED SIGNALING
Polypeptides are provided directed against IL-6R at specific dose ranges and dosing schedules that result in a prolonged effect on IL-6 mediated signaling. In...
2019/0119392 TREATMENT OF IL-6R RELATED DISEASES
Methods are provided for the treatment of IL-6R related diseases. More specifically, specific dose regimens and pre-filled syringes are provided for...
2019/0119391 ANTI-CXCR3 ANTIBODIES AND METHODS OF USE THEREOF
The present disclosure provides anti-CXCR3 antibodies and methods of using the antibodies to diagnose and/or treat CXCR3-associated disorders such as diabetes...
2019/0119390 Anti-CSF1R Antibodies for Treating PVNS
Methods of treating pigmented villonodular synovitis (PVNS) with antibodies that bind colony stimulating factor 1 receptor (CSF1R) are provided.
2019/0119389 Anti-Neuropilin Antigen-Binding Proteins and Methods of Use Thereof
Provided herein are antigen-binding proteins (ABPs) that selectively bind to NRP-1 and its isoforms and homologs, and compositions comprising the ABPs. Also...
2019/0119388 PHARMACEUTICAL COMPOSITION FOR INHIBITING METASTASIS OF CANCER, COMPRISING, AS ACTIVE INGREDIENT, ANTIBODY THAT...
The present invention provides a pharmaceutical composition for inhibiting the metastasis of cancer, comprising, as an active ingredient, an antibody that...
2019/0119387 INHIBITION OF TGFBETA IN IMMUNOTHERAPY
The invention relates to improved compositions and methods for treating diseases, such as cancer, by providing a combination therapy comprising a TGF.beta....
2019/0119386 ANTI-RYK ANTIBODIES AND METHODS OF USING THE SAME
Methods for inhibiting degeneration of a neuron, methods of treating a neurological/neurodegenerative disease, methods of modulating the directional growth of...
2019/0119385 HLA-G AS A NOVEL TARGET FOR CAR T-CELL IMMUNOTHERAPY
CAR cells targeting and antibodies human HLA-G are described as a new method of cancer treatment. It is proposed that HLA-G CAR cells are safe and effective in...
2019/0119384 HUMAN CTLA-4 ANTIBODIES AND THEIR USES
The presently subject matter provides novel human sequence antibodies against human CTLA-4 and methods of treating human diseases, infections and other...
2019/0119383 PROTEASE-ACTIVATED T CELL BISPECIFIC MOLECULES
The present invention generally relates to novel protease-activatable T cell activating bispecific molecules and idiotype-specific polypeptides. The present...
2019/0119382 BISPECIFIC CHIMERIC ANTIGEN RECEPTORS AND ENCODING POLYNUCLEOTIDES THEREOF
The invention is directed to a bispecific chimeric antigen receptor, comprising: (a) at least two antigen-specific targeting regions; (b) an extracellular...
2019/0119381 FULLY HUMAN ANTIBODIES TO BTLA
The present invention relates to binding compounds specific for BTLA and uses thereof. More specifically, the invention relates to fully human antibodies that...
2019/0119380 FUNCTIONAL PLASTICITY OF ILC2, IMMUNITY, AND COPD
The disclosure provides a method for treating or preventing a disease or disorder associated with lung inflammation by inhibiting the conversion of type 2...
2019/0119379 CANCER GENE THERAPY TARGETING CD47
Embodiments of the disclosure concern treatment of cancer utilizing methods and compositions that block CD47 such that tumor associated macrophages (TAMs) are...
2019/0119378 HUMANIZED ANTI-RAGE ANTIBODY
This invention provides a humanized, anti-human receptor for advance glycation end-products (RAGE) monoclonal antibody or a fragment of such antibody which...
2019/0119377 RECOMBINANT IGG FC MULTIMERS
This disclosure provides recombinant IgG Fc multimers and methods of treating autoimmune and inflammatory diseases by administering such multimers.
2019/0119376 ANTI-TIGIT ANTIBODIES AND METHODS OF USE
The invention provides anti-TIGIT (T-cell immunoreceptor with Ig and ITIM domains) antibodies and methods of using the same.
2019/0119375 Antibody Drug Conjugates
This application discloses anti-P-cadherin antibodies, antigen binding fragments thereof, and antibody drug conjugates of said antibodies or antigen binding...
2019/0119374 COMPOSITIONS AND METHODS FOR ANTIBODY PRODUCTION
Compositions and methods for minimizing antibody disulfide bond reduction are described. In one aspect, a composition is provided for culturing mammalian host...
2019/0119373 ANTIBODY RECOGNIZING HUMAN LEUKEMIA INHIBITORY FACTOR (LIF) AND USE OF ANTI-LIF ANTIBODIES IN THE TREATMENT OF...
The invention relates to antibodies directed against human Leukemia Inhibitory Factor (LIF) and to a hybridoma cell line producing said antibodies. The...
2019/0119372 USE OF IL-31 MONOCLONAL ANTIBODIES FOR ANTAGONIZING SIGNAL TRANSDUCTION IN DORSAL ROOT GANGLION CELLS
Use of antagonists to IL-31 are used to treat inflammation and pain by inhibiting, preventing, reducing, minimizing, limiting or minimizing stimulation in...
2019/0119371 ANTI-AGE ANTIBODIES FOR TREATING NEURODEGENERATIVE DISORDERS
A method of treating a neurodegenerative disorder or MD comprises administering to a subject a composition comprising an AGE antibody.
2019/0119370 MODIFIED ANTIBODY COMPOSITIONS, METHODS OF MAKING AND USING THEREOF
The present disclosure provides modified antibodies which contain an antibody or antibody fragment (AB) modified with a masking moiety (MM). Such modified...
2019/0119369 METHOD OF TREATING OR PREVENTING LIVER CONDITIONS
The present disclosure provides a method of treating a nonalcoholic fatty liver disease in a subject, the method comprising administering to the subject a...
2019/0119368 Method of Treating or Preventing Rheumatoid Arthritis
This invention is in the field of treating or preventing inflammation in humans and animals and relates to pharmaceutical compositions and methods for treating...
2019/0119367 ANTIBODIES THAT BIND PEPTIDOGLYCAN RECOGNITION PROTEIN 1
Disclosed herein is a method for identifying TREM-1's ligand and antibodies, or fragments thereof, which are capable of modifying the function of TREM-1's...
2019/0119366 METHOD FOR TREATING BREAST CANCER
Breast cancer cells lacking ER protein expression, PgR protein expression and/or showing absence of HER2 protein over-expression (i.e., triple-negative breast...
2019/0119365 HUMANIZED ANTIBODIES SPECIFIC TO THE PROTOFIBRILLAR FORM OF THE BETA-AMYLOID PEPTIDE
Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide are provided. Methods of using antibodies specific to the protofibrillar...
2019/0119364 COMPOUNDS AND COMPOSITIONS USEFUL FOR TREATING METABOLIC SYNDROME, AND METHODS USING SAME
The present invention includes a method of treating and/or preventing metabolic syndrome in a subject in need thereof. In certain embodiments, the method...
2019/0119363 ENANTIOPURE HAPTENS FOR NICOTINE VACCINE DEVELOPMENT
The invention provides chiral haptens (-)-3'-AmNic and (-)-N4N for use in generating antibodies in a patient specific for (-)-nicotine. The haptens can be...
2019/0119362 METHOD FOR PRODUCING PROTEIN INCLUDING k CHAIN VARIABLE REGION
A method for producing a protein includes adsorbing a protein including a .kappa. chain variable region on an insoluble carrier of an affinity separation...
2019/0119361 IMMUNOGLOBULIN FRAMEWORKS WHICH DEMONSTRATE ENHANCED STABILITY IN THE INTRACELLULAR ENVIRONMENT AND METHODS OF...
Compositions are provided, which can be used as frameworks for the creation of very stable and soluble single-chain Fv antibody fragments. These frameworks...
2019/0119360 TEMPERATURE SHIFT FOR HIGH YIELD EXPRESSION OF POLYPEPTIDES IN YEAST AND OTHER TRANSFORMED CELLS
Methods for producing heterologous proteins arc disclosed. In particular, the present disclosure provides improved methods of producing desired proteins,...
2019/0119359 Novel Antibody Frameworks
The present invention relates to novel antibody frameworks with advantageous properties.
2019/0119358 RAS BINDING PEPTIDES AND METHODS OF USE
The present invention provides Ras modulators including inhibitors and/or antagonists of Ras, Ras binding, and Ras-dependent cell signaling activity. Also...
2019/0119357 MESSENGER RIBONUCLEIC ACIDS FOR THE PRODUCTION OF INTRACELLULAR BINDING POLYPEPTIDES AND METHODS OF USE THEREOF
The invention features isolated mRNAs encoding fusion polypeptides comprising a Stefm A (SteA) scaffold polypeptide and one or more binding polypeptides, such...
2019/0119356 MODIFIED TRANSFERRIN DNA BINDING DOMAIN, RECOMBINANT DNA POLYMERASE AND PREPARATION METHOD
A modified transferrin DNA binding domain. The transferrin is lactotransferrin (LTF), serotransferrin (TF), melanotransferrin (MTF) or ovotransferrin (OTF),...
2019/0119355 Optimal Interstrand Bridge for Collagen Mimics
Novel collagen-mimetic peptides are disclosed comprising the formula (Xaa-Yaa-Gly).sub.n, where the amino acid at one of the Xaa positions is substituted with...
2019/0119354 CONTAMINANT REMOVAL METHOD
A method for purifying Apo A-I is provided including the steps of providing a solution comprising Apo A-I and guanidine hydrochloride and filtering the...
2019/0119353 IMMUNOTHERAPEUTICS FOR CANCER AND AUTOIMMUNE DISEASES
Chimeric fusion proteins and polynucleotides encoding the chimeric fusion proteins are provided for the treatment of proliferative disorders, automimmune...
2019/0119352 NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates...
2019/0119351 NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates...
2019/0119350 NY-ESO-1 SPECIFIC TCRS AND METHODS OF USE THEREOF
The present disclosure relates to NY-ESO-1 specific TCR amino acid sequences and methods of their use.
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.